Health Condition 1: null- adult patients receiving care for either asthma, allergic rhinitis (AR), chronic obstructive pulmonary disease (COPD), or rhinosinusitis
Conditions
Interventions
Sponsors
MSD Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: A subject must meet all the criteria listed below to be eligible. 1.Each subject (or subjects legal representative) must be willing and able to provide written informed consent for the study. 2.Each subject must be greater than equal to 18 years of age. A subject may be of either sex, and any race or ethnicity. 3.Each subject must have presented to the study site to receive care for a new or existing diagnosis of asthma, allergic rhinitis, COPD or rhinosinusitis. 4. Each subject must be capable of reading and/or comprehending one of the languages of the Informed Consent Form (ICF) and patient survey documents.
Exclusion criteria
Exclusion criteria: A subject meeting any of the exclusion criteria listed below must be excluded from participating in the study: The subject has participated in any interventional clinical study within the 12 weeks prior to entering the current study. The subject or a family member is among the personnel of the investigational or Sponsor staff directly involved with this study. The subject was screened and consented (enrolled) to participate in this study at a previous visit to the physician or at any other study site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the proportion of adult patients receiving care for either asthma, allergic rhinitis (AR), chronic obstructive pulmonary disease (COPD), or rhinosinusitis among patients receiving care for a respiratory disease, as diagnosed by the physician.Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To estimate the proportion of patients receiving care for asthma, AR, COPD, or rhinosinusitis who are newly diagnosed. 2. To estimate the proportion of patients receiving care for asthma, AR, COPD, or rhinosinusitis who have combinations of the four diseases. 3. (a) To estimate the proportion receiving care for asthma, AR, COPD, or rs who report cough as a symptom. (b) To estimate the proportion receiving care for asthma, AR, COPD, or rs who report cough as the main reason.Timepoint: 1 year | — |
Countries
India, Malaysia, Republic of Korea, Singapore, Taiwan, Thailand
Contacts
Public ContactDr Susmita Kundu
National Allergy Asthma Bronchitis Institute
Outcome results
None listed